Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
3.110
+0.320 (11.47%)
At close: Jun 3, 2026, 4:00 PM EDT
3.100
-0.010 (-0.32%)
Pre-market: Jun 4, 2026, 5:13 AM EDT
Equillium Market Cap
Equillium has a market cap or net worth of $196.63 million as of June 3, 2026. Its market cap has increased by 1,371.92% in one year.
Market Cap
196.63M
Enterprise Value
136.00M
1-Year Change
1,371.92%
Ranking
Category
Stock Price
$3.11
Market Cap Chart
Since October 12, 2018, Equillium's market cap has decreased from $234.54M to $196.63M, a decrease of -16.16%. That is a compound annual growth rate of -2.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 176.40M | 86.90% |
| Dec 31, 2025 | 94.38M | 256.04% |
| Dec 31, 2024 | 26.51M | 4.40% |
| Dec 29, 2023 | 25.39M | -30.27% |
| Dec 30, 2022 | 36.41M | -67.14% |
| Dec 31, 2021 | 110.80M | -16.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Milestone Pharmaceuticals | 181.63M |
| Tenaya Therapeutics | 180.17M |
| MediWound | 177.49M |
| OnKure Therapeutics | 175.32M |
| Tiziana Life Sciences | 173.92M |
| Acumen Pharmaceuticals | 173.35M |
| Innate Pharma | 172.68M |
| NRx Pharmaceuticals | 171.93M |